Clinical trial

Magnetic Resonance Imaging of Lymph Nodes Using Ferumoxytol in Patients With…

NCT00087347 · Massachusetts General Hospital, Other · Completed

Key facts

NCT number NCT00087347
Title Magnetic Resonance Imaging of Lymph Nodes Using Ferumoxytol in Patients With Primary Prostate or Breast Cancer
Official title An NCI-Sponsored Exploratory Study For Determining Optimum Timing For The Imaging Of Intravenous Superparamagnetic Particle Ferumoxytol (Code7228) For The Differentiation of Metastatic and Non Metastatic Lymph Nodes in Patients With Known Primary Cancer Scheduled For Possible Surgical Lymph Node…
Lead sponsor Massachusetts General Hospital, Other
Collaborators National Cancer Institute (NCI) NIH
Status Completed
Study type Observational
Conditions Breast Cancer, Prostate Cancer
Intervention type Drug, Procedure
Interventions ferumoxytol, magnetic resonance imaging
Enrollment 14
Start date Sep 1, 2004
Primary completion Sep 1, 2006
First posted Jul 12, 2004
Last update posted May 14, 2013
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies